FDA

Unlike the initial rollout of the COVID-19 vaccine to long-term care providers in late 2020 and early 2021, providers will be on their own to secure access to and administer booster doses, which are expected...

Senior living industry executives are banking on the U.S. Food and Drug Administration’s approval of the first COVID-19 vaccine as the confirmation that vaccine-hesitant staff members need to finally...

Three members of a Food & Drug Administration advisory panel resigned this week over the agency’s controversial decision on Monday to approve a novel therapy for Alzheimer’s disease.